Skip to main content
. 2026 Aug 26;17:1897246. doi: 10.3389/fphar.2026.1897246

FIGURE 2.

Line graph comparing 24-hour proteinuria (grams per day) over 9 months of treatment among Support, Glucocorticoids, and Nefecon groups. All groups show decreasing trends, with Nefecon starting highest and converging near others by month 9. Double asterisks indicate significant differences at 3, 6, and 9 months.

The 24-h urine protein quantification (24 h-UPro) levels during the follow-up period were measured in the Support group, the Glucocorticoids group, and the Nefecon group. The points represent the median of 24 h-UPro, and the error bars indicate the 25th and 75th percentiles (IQR). Within the Nefecon group, comparisons at each time point with the baseline were made, with *P < 0.05 and **P < 0.01; there was no statistically significant difference in 24 h-UPro levels among the three groups (P > 0.05).